Article
Fabry disease: Mechanism and therapeutics strategies
26 Oct 2022
Abstract excerpt
Fabry disease is a monogenic disease characterized by a deficiency or loss of the α-galactosidase A (GLA). The resulting impairment in lysosomal GLA enzymatic activity leads to the pathogenic accumulation of enzymatic substrate and, consequently, the progressive appearance of clinical symptoms in target organs, including the heart, kidney, and brain. However, the mechanisms involved in Fabry disease-mediated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
